Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05023252 · ClinicalTrials.gov registry record · NA

Mobile Self-Tracking of Mental Health

A NA study of Schizophrenia and Bipolar Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
87
Enrollment target
1
Study location

NCT05023252 is a NA study of Schizophrenia and Bipolar Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 87 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05023252, a NA study of Schizophrenia and Bipolar Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
87 participants
Enrollment target
1
Study location

Study Summary

Serious mental illnesses require years of monitoring and adjustments in treatment. Stress, substance abuse or reduced medication adherence cause rapid worsening of symptoms, with consequences that include job loss, homelessness, suicide, incarceration, and hospitalization. Treatment visits can be infrequent. Illness exacerbations usually occur with no clinician awareness, leaving little opportunity to make treatment adjustments. Tools are needed that quickly detect illness worsening. At least two thirds of Veterans with serious mental illness use a smartphone. These phones generate data that characterize sociability, activity and sleep. Changes in these are warning signs for relapse. Members of this project developed an app that monitors and transmits these mobile data. This project studies passive mobile sensing that allows Veterans to self-track their activities, sociability and sleep; and studies whether this can be used to track symptoms. The project intends to produce a mobile platform that monitors the clinical status of patients, identifies risk for relapse, and allows early intervention.

Interventions

  • OTHER mobile application

Study Locations (1)

California

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2021-10-18
Est. Completion 2024-07-22
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05023252

The ClinicalTrials.gov registry entry for NCT05023252 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (60% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which mobile application is the first listed.

NCT05023252 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05023252 about?

NCT05023252 is a clinical study titled "Mobile Self-Tracking of Mental Health". Serious mental illnesses require years of monitoring and adjustments in treatment. Stress, substance abuse or reduced medication adherence cause rapid worsening of symptoms, with consequences that include job loss, homelessness, suicide, incarceration, and hospitalization. Treatment visits can be in...

What is the current status of trial NCT05023252?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2021-10-18. Estimated completion is 2024-07-22.

What conditions does trial NCT05023252 study?

This clinical trial studies the following conditions: Schizophrenia, Bipolar Disorder, Post Traumatic Stress Disorder, Schizoaffective Disorder.

What interventions are being tested in trial NCT05023252?

The interventions under investigation include: mobile application (OTHER).

Who is sponsoring clinical trial NCT05023252?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05023252 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.